Discovery on Target
Discovery on Target Mobile Header

 

Join us in Boston!
November 2-4, 2011

Thank you to all of our speakers, sponsors, and exhibitors for your support and contribution, and to all the delegates for your participation.
The success of this event is largely due to the dedicated participants that return with us year after year.

If you would like to share your feedback, or give input for next year’s event, please contact Margit Eder at meder@healthtech.com

Discovery on Target 2010


Concurrent Tracks | November 2-3, 2010 

HDAC Inhibitors

GPCR-Based Drug Discovery

Ion Channels as Therapeutic Targets

Targeting the P13K Pathway 

Concurrent Tracks | November 3-4, 2010 

RNAi for Functional Screens
The Challenge of Developing Kinase Inhibitors
Diabetes Drug Discovery
New Ways to Tackle COPD and Other Chronic Pulmonary Diseases 

 
 
  


CONFERENCE SHORT COURSES*

Allosteric Modulators of GPCRs  

Structure-Based Design of Ion Channel – Linked Receptors   

Best Practices for Setting Up Effective RNAi Screens  

In vivo Discovery and Validation Using RNAi  

Assessing Cardio Safety of Diabetes Drug Candidates  

*Separate registration required. 


CONFIRMED KEYNOTE SPEAKERS

Edward Seto, Ph.D. 

Chairman, Department of Molecular Oncology, H. Lee Moffitt Cancer Center 

Gregory J. Kaczorowski, Ph.D. 

Adjunct Professor, Physiology and Pharmacology, New Jersey Medical School; Adjunct Professor, Physiology and Biophysics, Robert Wood Johnson Medical School 

Laszlo Kiss, Ph.D. 

Senior Research Fellow, Merck Research Laboratories 

Spyro Mousses, Ph.D. 

Vice President, Office of Innovation and Director, Center of BioIntelligence, Translational Genomics Research Institute 

Jorge Plutzky, M.D. 

Director, The Vascular Disease Prevention Program, Cardiovascular Division, Brigham and Women’s Hospital and Associate Professor, Harvard Medical School 

Thomas Sakmar, M.D. 

Professor, Molecular Biology and Biochemistry, Rockefeller University 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Final Agenda Now Available

Final Agenda Now Available


 PREMIER SPONSOR

Cellecta

Arrow DownCONFERENCE-AT-A-GLANCE

Arrow DownDOWNLOAD 2016 BROCHURE

Arrow OverSHORT COURSES

Arrow OverVIEW ALL SPONSORS

Arrow OverVIEW MEDIA PARTNERS


SPONSORSHIPS & EXHIBITS

The exhibit hall was sold out in 2015, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2016, contact:

Jon Stroup
Sr. Business Development Manager
781-972-5483
jstroup@healthtech.com

 

Sponsorship-vid

DOT-Vid-recap 

IPR-Special-Report-Packages  

SEPTEMBER 19 SYMPOSIA:

Next-Generation Histone Deacetylase Inhibitors

Strategies for Tackling Rare Genetic Diseases

Understanding CRISPR: Mechanisms and Applications

Autoimmunity – Small Molecule Approaches

NK Cell-Based Cancer Immunotherapy

CONFERENCES

SEPTEMBER 20-21

Targeting Histone Methyltransferases and Demethylases

Targeting the Ubiquitin Proteasome System

Targeting the Microbiome
– Part 1

GPCR-Based Drug Discovery - Part 1

Advances in Gene Editing and Gene Silencing – Part 1

Gene Therapy Breakthroughs

Antibodies Against Membrane Protein Targets – Part 1

Targeting Cardio-Metabolic Diseases

Targeting Ocular Disorders

SEPTEMBER 21-22

Targeting Epigenetic Readers and Chromatin Remodelers

Kinase Inhibitor Discovery

Targeting the Microbiome
– Part 2

GPCR-Based Drug Discovery - Part 2

Advances in Gene Editing and Gene Silencing – Part 2

Translating Cancer Genomics

Antibodies Against Membrane Protein Targets – Part 2

Metabolomics in Drug Discovery

TRAINING SEMINAR: Data Visualization

Monday, September 19 | 8:00 - 11:00 am

(SC1) Immunology Basics for Chemists

(SC2) Designing Peptide Therapeutics for Specific PPIs

(SC3) Phenotypic Screening and Chemical Probe Development

(SC4) Medical Dermatology Therapeutic R&D and Technical Innovation - Part 1

Monday, September 19 | 12:00 - 3:00 pm

(SC5) GPCR Structure-Based Drug Discovery

(SC6) RNA as a Small Molecule Drug Target

(SC7) Using IP Landscape Studies to Improve Your Confidence

(SC8) Medical Dermatology Therapeutic R&D and Technical Innovation - Part 2

Monday, September 19 | 3:30 - 6:30 pm

(SC9) Targeting of GPCRs with Monoclonal Antibodies

(SC10) Introduction to Targeted Covalent Inhibitors

(SC11) Contact Lens Drug Delivery Systems

(SC12) Introduction to Gene Editing

Monday, September 19 | 7:00 - 9:30 pm

T(SC13) Convergence of Immunotherapy and Epigenetics for Cancer Treatment

Wednesday, September 21 , 7:00 - 9:30 pm

(SC14) Cancer Metabolism: Pathways, Targets and Clinical Updates

(SC15) Introduction to Allosteric Modulators and Biased Ligands of GPCRs

(SC16) Functional Screening Strategies Using CRISPR and RNAi

(SC17) Challenges and Opportunities in DNA Methyl Transferase (DNMT) Inhibitors as Therapeutics